Atnahs is a life cycle management company dedicated to realizing the full potential of established medicines. With over 20 brands and a presence in more than 160 markets, we leverage patient and clinician insights to identify areas of ongoing unmet need. Through our expertise as a leader in life cycle management, we find innovative ways to deliver better outcomes for patients.

In the field of cardiovascular medicine, our key products include Inderal®, Tenormin®, Tenoretic®, Zestril®, and Zestoretic®. In endocrinology, we offer Bonviva®, Rocaltrol®, and Synacthen®. Our neurology portfolio features Anaprox®, Naprosyn®, Toradol®, and Valium®, while our oncology offerings include Bondronat®, Dipentum®, and Kytril®.

We pride ourselves on being a collaborative and experienced partner. Working with innovative pharma, digital health pioneers, tech platforms, distributors, and suppliers, we aim to sustainably improve the patient experience and the communities we serve. At Atnahs, we value our people and foster an inclusive, high-performance culture.

Join our team of inquisitive minds to continually learn, develop, and drive change in the healthcare industry. Stay updated with our latest news and milestones, such as our commitment to a sustainable future and our strategic partnerships for precision medicine combination therapeutics. Contact us at Sovereign House, Miles Gray Road, Basildon, UK, or visit our website for more information